Cao Y, Zhang H, Luo N, Li H, Cheng L, Huang W
Qual Life Res. 2024; 33(12):3309-3322.
PMID: 39225938
DOI: 10.1007/s11136-024-03774-1.
Kim DeLuca E, Dalziel K, Wittenberg E, Henderson N, Prosser L
Health Qual Life Outcomes. 2024; 22(1):53.
PMID: 38987772
PMC: 11238509.
DOI: 10.1186/s12955-024-02268-5.
Tsui T, Torres S, Bielecki J, Mitsakakis N, Trudeau M, Bremner K
Health Qual Life Outcomes. 2024; 22(1):38.
PMID: 38745165
PMC: 11094879.
DOI: 10.1186/s12955-024-02253-y.
Fernando-Canavan L, Abraham P, Devlin N, Tran-Duy A
Qual Life Res. 2023; 33(5):1157-1174.
PMID: 38079025
DOI: 10.1007/s11136-023-03554-3.
Yin Y, Peng Q, Ma L, Dong Y, Sun Y, Xu S
Qual Life Res. 2023; 33(3):753-765.
PMID: 38079024
DOI: 10.1007/s11136-023-03562-3.
Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer.
Bulamu N, Mpundu-Kaambwa C, OCallaghan M, Kaambwa B
BMC Cancer. 2023; 23(1):297.
PMID: 37005587
PMC: 10067207.
DOI: 10.1186/s12885-023-10732-6.
Self-managed physical activity in cancer survivors for the management of cancer-related fatigue: A scoping review.
Campanini I, Ligabue M, Bo M, Bassi M, Lusuardi M, Merlo A
PLoS One. 2022; 17(12):e0279375.
PMID: 36542639
PMC: 9770433.
DOI: 10.1371/journal.pone.0279375.
Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.
Tsui T, Trudeau M, Mitsakakis N, Krahn M, Davis A
MDM Policy Pract. 2022; 7(2):23814683221142267.
PMID: 36532295
PMC: 9747890.
DOI: 10.1177/23814683221142267.
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.
Royle K, Coulson A, Ramasamy K, Cairns D, Hockaday A, Quezada S
BMJ Open. 2022; 12(11):e063037.
PMID: 36396306
PMC: 9677008.
DOI: 10.1136/bmjopen-2022-063037.
Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.
Tsui T, Trudeau M, Mitsakakis N, Torres S, Bremner K, Kim D
PLoS One. 2022; 17(2):e0262635.
PMID: 35120148
PMC: 8815914.
DOI: 10.1371/journal.pone.0262635.
Transforming challenges into opportunities: conducting health preference research during the COVID-19 pandemic and beyond.
Kaur M, Skolasky R, Powell P, Xie F, Huang I, Kuspinar A
Qual Life Res. 2021; 31(4):1191-1198.
PMID: 34661806
PMC: 8521079.
DOI: 10.1007/s11136-021-03012-y.
Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu N, Vissapragada R, Chen G, Ratcliffe J, Mudge L, Smithers B
Health Qual Life Outcomes. 2021; 19(1):233.
PMID: 34600554
PMC: 8487554.
DOI: 10.1186/s12955-021-01867-w.
Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases.
Jayasundera K, Abuzaitoun R, Lacy G, Abalem M, Saltzman G, Ciulla T
Am J Ophthalmol. 2021; 235:90-97.
PMID: 34433085
PMC: 8861129.
DOI: 10.1016/j.ajo.2021.08.009.
Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment.
Finch A, Gamper E, Norman R, Viney R, Holzner B, King M
Pharmacoeconomics. 2021; 39(9):1085-1098.
PMID: 34216380
PMC: 8352836.
DOI: 10.1007/s40273-021-01058-x.
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms.
Shah K, Bennett B, Lenny A, Longworth L, Brazier J, Oppe M
Eur J Health Econ. 2021; 22(8):1301-1309.
PMID: 34142266
PMC: 8526451.
DOI: 10.1007/s10198-021-01337-6.
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer.
Tu M, Clemons M, Stober C, Jeong A, Vandermeer L, Mates M
Curr Oncol. 2021; 28(3):1847-1856.
PMID: 34068083
PMC: 8161812.
DOI: 10.3390/curroncol28030171.
Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument.
Kularatna S, Rowen D, Mukuria C, McPhail S, Chen G, Mulhern B
Qual Life Res. 2021; 31(1):257-268.
PMID: 34037917
DOI: 10.1007/s11136-021-02884-4.
Dimensions Used in Instruments for QALY Calculation: A Systematic Review.
Toure M, Kouakou C, Poder T
Int J Environ Res Public Health. 2021; 18(9).
PMID: 33919471
PMC: 8122477.
DOI: 10.3390/ijerph18094428.
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.
Terpos E, Mikhael J, Hajek R, Chari A, Zweegman S, Lee H
Blood Cancer J. 2021; 11(2):40.
PMID: 33602913
PMC: 7891472.
DOI: 10.1038/s41408-021-00432-4.
Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure: Valuation of Recovering Quality of Life Utility Index.
Keetharuth A, Rowen D, Bjorner J, Brazier J
Value Health. 2021; 24(2):281-290.
PMID: 33518035
PMC: 7871010.
DOI: 10.1016/j.jval.2020.10.012.